Newron Pharmaceuticals SpA
FSX:NP5.DE
8.76 (EUR) • At close September 6, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 9.469 | 6.094 | 5.762 | 5.258 | 7.038 | 4.025 | 13.428 | 6.726 | 2.38 | 1.557 | 3.539 | 8.924 | 0.28 | 0.806 | 2.542 | 3.933 | 4.024 | 1.191 | 0 |
| Kosten van de omzet
| 0 | 0 | 0 | 0.295 | 1.425 | 1.372 | 0 | 2.634 | 1.262 | 0.477 | 0.269 | 0.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 9.469 | 6.094 | 5.762 | 4.963 | 5.613 | 2.653 | 13.428 | 4.092 | 1.118 | 1.08 | 3.27 | 8.896 | 0.28 | 0.806 | 2.542 | 3.933 | 4.024 | 1.191 | 0 |
| Brutowinstmarge
| 1 | 1 | 1 | 0.944 | 0.798 | 0.659 | 1 | 0.608 | 0.47 | 0.694 | 0.924 | 0.997 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Onderzoek- en ontwikkelingskosten
| 13.678 | 12.005 | 10.725 | 10.354 | 12.01 | 4.936 | 8.596 | 12.398 | 18.449 | 6.017 | 4.537 | 3.534 | 3.822 | 15.922 | 18.544 | 12.881 | 8.197 | 11.488 | 10.599 |
| Algemene en administratieve kosten
| 3.982 | 3.536 | 3.493 | 4.928 | 6.419 | 5.152 | 3.956 | 4.588 | 4.291 | 3.613 | 3.791 | 4.151 | 6.898 | 6.451 | 8.468 | 9.256 | 9.447 | 6.619 | 4.544 |
| Verkoop- en marketingkosten
| 0.08 | 0.081 | 0.038 | 0.331 | 0.634 | 0.406 | 0.708 | 0.513 | 0.053 | 0.053 | 0.015 | 0.062 | 0.051 | 0.073 | 0.086 | 0.115 | 0.131 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 7.739 | 3.617 | 3.531 | 5.259 | 7.053 | 5.558 | 4.664 | 5.101 | 4.344 | 3.666 | 3.806 | 4.213 | 6.949 | 6.524 | 8.554 | 9.371 | 9.578 | 6.619 | 4.544 |
| Overige kosten
| 0 | 3.774 | 3.863 | 7.416 | 7.449 | 7.137 | 4.514 | 4.552 | 3.987 | 3.089 | 2.972 | 3.874 | -0.01 | 0 | 0 | 0 | 0 | -0.164 | -0.067 |
| Bedrijfskosten
| 21.417 | 19.396 | 18.119 | 23.029 | 26.512 | 17.631 | 17.774 | 22.051 | 26.78 | 12.772 | 11.315 | 11.621 | 6.762 | 22.446 | 27.098 | 22.252 | 17.775 | 17.943 | 15.076 |
| Bedrijfsresultaat
| -12.158 | -13.302 | -12.357 | -18.066 | -20.899 | -14.978 | -4.346 | -15.325 | -24.4 | -11.215 | -7.776 | -2.697 | -6.482 | -21.64 | -24.556 | -18.319 | -13.681 | -16.752 | -15.076 |
| Bedrijfsresultaat ratio
| -1.284 | -2.183 | -2.145 | -3.436 | -2.969 | -3.721 | -0.324 | -2.278 | -10.252 | -7.203 | -2.197 | -0.302 | -23.15 | -26.849 | -9.66 | -4.658 | -3.4 | -14.065 | 0 |
| Totaal overige inkomsten en kosten netto
| -4.779 | -4.17 | -2.527 | -1.552 | 0.737 | -0.041 | -0.955 | 2.755 | 0.679 | 0.492 | 0.063 | 0.228 | 0.045 | -0.033 | 0.205 | 1.963 | 2.593 | 0.351 | 0.157 |
| Inkomen voor belasting
| -16.937 | -17.472 | -14.884 | -19.618 | -20.162 | -15.019 | -5.301 | -15.204 | -24.983 | -10.723 | -7.713 | -2.497 | -6.437 | -21.673 | -24.351 | -16.356 | -11.088 | -16.401 | -14.919 |
| Inkomen voor belasting ratio
| -1.789 | -2.867 | -2.583 | -3.731 | -2.865 | -3.731 | -0.395 | -2.26 | -10.497 | -6.887 | -2.179 | -0.28 | -22.989 | -26.89 | -9.579 | -4.159 | -2.755 | -13.771 | 0 |
| Belastingkosten
| 0.025 | 0.021 | 0.017 | 1.38 | 0.045 | 0.016 | -0.019 | 0.033 | -2.167 | -0.628 | -0.615 | -0.122 | 0.008 | -1.128 | -0.87 | 0.008 | 0.001 | -0.351 | -0.157 |
| Nettowinst
| -16.962 | -17.493 | -14.901 | -20.998 | -20.207 | -15.035 | -5.282 | -15.237 | -22.816 | -10.095 | -7.098 | -2.375 | -6.445 | -20.545 | -23.481 | -16.364 | -11.089 | -16.401 | -14.919 |
| Nettowinstmarge
| -1.791 | -2.871 | -2.586 | -3.994 | -2.871 | -3.735 | -0.393 | -2.265 | -9.587 | -6.484 | -2.006 | -0.266 | -23.018 | -25.49 | -9.237 | -4.161 | -2.756 | -13.771 | 0 |
| WPA (Winst Per Aandeel)
| -0.95 | -0.98 | -0.84 | -1.18 | -1.13 | -0.84 | -0.32 | -1.04 | -1.66 | -0.8 | -0.62 | -0.29 | -0.89 | -3.11 | -3.86 | -2.74 | -1.9 | -4.33 | -5.29 |
| Verwaterde WPA
| -0.95 | -0.98 | -0.84 | -1.18 | -1.13 | -0.84 | -0.32 | -1.04 | -1.66 | -0.8 | -0.62 | -0.29 | -0.89 | -3.11 | -3.86 | -2.74 | -1.9 | -4.33 | -5.29 |
| EBITDA
| -11.948 | -13.323 | -11.757 | -17.16 | -19.383 | -14.916 | -5.168 | -15.039 | -23.745 | -11.182 | -7.737 | -2.418 | -6.332 | -21.491 | -24.032 | -18.048 | -13.538 | -16.752 | -15.076 |
| EBITDA ratio
| -1.262 | -2.186 | -2.04 | -3.264 | -2.754 | -3.706 | -0.385 | -2.236 | -9.977 | -7.182 | -2.186 | -0.271 | -22.614 | -26.664 | -9.454 | -4.589 | -3.364 | -14.065 | 0 |